Literature DB >> 15236019

Sevoflurane anesthesia for elective cesarean section.

A Asada1, M Fujimori, S Tomoda, A Hidaka.   

Abstract

Sevoflurane anesthesia was given to sixteen women who had been scheduled for elective cesarean section. The maternal systolic blood pressure significantly decreased during the anesthesia induction. Both the anesthesia induction and emergence were smooth and rapid. These findings were supported partially by the pharmacokinetic analysis of sevoflurane concentration in the maternal artery and expired gas mixture. Spontaneous uterine contractions were good in 12 patients, fair in two and poor in two. The measured blood loss was 752 +/- 257 ml including amniotic fluid. No blood transfusion was given to any patient. The median value of the Apgar score at one minute was seven (range three to nine). No neonate was intubated for resuscitation. No abnormal maternal laboratory data were found, including liver and kidney function tests and blood cell counts one week after the operation. No adverse effect of sevoflurane on the neonate was found one week after the delivery and three months after the discharge.

Entities:  

Year:  1990        PMID: 15236019     DOI: 10.1007/s0054000040066

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  15 in total

1.  Clinical investigations concerning the use of Ethrane for Cesarean section.

Authors:  W Dick; E Knoche; E Traub
Journal:  J Perinat Med       Date:  1979       Impact factor: 1.901

2.  Clinical evaluation and metabolism of sevoflurane in patients.

Authors:  H Kikuchi; M Morio; K Fujii; K Mukaida; M Horibe; T I Davidkova; S Kawachi; N Sato
Journal:  Hiroshima J Med Sci       Date:  1987-03

3.  Effects of maternal hyperventilation on uterine blood flow and fetal oxygenation and acid-base status.

Authors:  G Levinson; S M Shnider; A A DeLorimier; J L Steffenson
Journal:  Anesthesiology       Date:  1974-04       Impact factor: 7.892

4.  [Measurement of ethrane by gas chromatography. 1].

Authors:  M Kudo; T Oyama
Journal:  Masui       Date:  1971-11

5.  Sevoflurane: a new inhalational anesthetic agent.

Authors:  R F Wallin; B M Regan; M D Napoli; I J Stern
Journal:  Anesth Analg       Date:  1975 Nov-Dec       Impact factor: 5.108

6.  Partition coefficients for sevoflurane in human blood, saline, and olive oil.

Authors:  D P Strum; E I Eger
Journal:  Anesth Analg       Date:  1987-07       Impact factor: 5.108

7.  Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers.

Authors:  D A Holaday; F R Smith
Journal:  Anesthesiology       Date:  1981-02       Impact factor: 7.892

8.  Respiratory effects of sevoflurane.

Authors:  M Doi; K Ikeda
Journal:  Anesth Analg       Date:  1987-03       Impact factor: 5.108

9.  Comparison of the maternal and neonatal effects of halothane, enflurane, and isoflurane for cesarean delivery.

Authors:  T M Warren; S Datta; G W Ostheimer; J S Naulty; J B Weiss; J A Morrison
Journal:  Anesth Analg       Date:  1983-05       Impact factor: 5.108

10.  Comparative maternal and neonatal effects of halothane and enflurane for cesarean section.

Authors:  T K Abboud; S H Kim; E H Henriksen; T Chen; R Eisenman; G Levinson; S M Shnider
Journal:  Acta Anaesthesiol Scand       Date:  1985-10       Impact factor: 2.105

View more
  3 in total

1.  Effect of decreased fetal perfusion on placental clearance of volatile anesthetics in a dual perfused human placental cotyledon model.

Authors:  Ryusuke Ueki; Tsuneo Tatara; Nobutaka Kariya; Noriko Shimode; Munetaka Hirose; Chikara Tashiro
Journal:  J Anesth       Date:  2014-01-03       Impact factor: 2.078

2.  Comparison of sevoflurane and other volatile anesthetics for cesarean section.

Authors:  K Kan; A Shigihara; C Tase; A Okuaki
Journal:  J Anesth       Date:  1995-12       Impact factor: 2.078

3.  Comparison of the effects of sevoflurane and isoflurane anesthesia on the maternal-fetal unit in sheep.

Authors:  Toshiyuki Okutomi; Robert A Whittington; Deborah J Stein; Hisayo O Morishima
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.